Gemini BioProducts Holding, Inc. (GeminiBio), a portfolio company of BelHealth Investment Partners, LLC (BelHealth), announced on Thursday that it has named Gopi Natarajan as its new director.
Natarajan has over thirty-five years of leadership experience in the healthcare industry. He co-Founded Omega Healthcare and held the position of chief executive officer for 18 years.
Harold S. Blue, Managing Partner of BelHealth Investment Partners, said, 'I have known Gopi for over 25 years and our predecessor fund was the first institutional investor in Omega back in 2006 and is now the leading RCM company backed by Goldman Sachs and Everstone Capital. He has stellar leadership and operational skills and will assist the GeminiBio team execute during its imminent growth phase. I am looking forward to working closely with Gopi again.'
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation